Rigel Pharmaceuticals Stock Forecast - Simple Exponential Smoothing
| RIGL Stock | USD 46.22 2.38 5.43% |
The Simple Exponential Smoothing forecasted value of Rigel Pharmaceuticals on the next trading day is expected to be 46.20 with a mean absolute deviation of 1.23 and the sum of the absolute errors of 73.82. Rigel Stock Forecast is based on your current time horizon. Although Rigel Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Rigel Pharmaceuticals' systematic risk associated with finding meaningful patterns of Rigel Pharmaceuticals fundamentals over time.
At this time, Rigel Pharmaceuticals' Inventory Turnover is quite stable compared to the past year. Payables Turnover is expected to rise to 9.78 this year, although the value of Receivables Turnover will most likely fall to 4.09. . Common Stock Shares Outstanding is expected to rise to about 19.1 M this year, although the value of Net Loss will most likely fall to (70.7 M). Open Interest Against 2026-01-16 Rigel Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Rigel Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Rigel Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Rigel Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Rigel Pharmaceuticals' open interest, investors have to compare it to Rigel Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Rigel Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Rigel. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Rigel Pharmaceuticals Simple Exponential Smoothing Price Forecast For the 25th of November
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Rigel Pharmaceuticals on the next trading day is expected to be 46.20 with a mean absolute deviation of 1.23, mean absolute percentage error of 3.76, and the sum of the absolute errors of 73.82.Please note that although there have been many attempts to predict Rigel Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Rigel Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Rigel Pharmaceuticals Stock Forecast Pattern
| Backtest Rigel Pharmaceuticals | Rigel Pharmaceuticals Price Prediction | Buy or Sell Advice |
Rigel Pharmaceuticals Forecasted Value
In the context of forecasting Rigel Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Rigel Pharmaceuticals' downside and upside margins for the forecasting period are 40.33 and 52.06, respectively. We have considered Rigel Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Rigel Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Rigel Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 117.5965 |
| Bias | Arithmetic mean of the errors | -0.1627 |
| MAD | Mean absolute deviation | 1.2304 |
| MAPE | Mean absolute percentage error | 0.0349 |
| SAE | Sum of the absolute errors | 73.8234 |
Predictive Modules for Rigel Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Rigel Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Rigel Pharmaceuticals
For every potential investor in Rigel, whether a beginner or expert, Rigel Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Rigel Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Rigel. Basic forecasting techniques help filter out the noise by identifying Rigel Pharmaceuticals' price trends.Rigel Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Rigel Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Rigel Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Rigel Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Rigel Pharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Rigel Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Rigel Pharmaceuticals' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Rigel Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Rigel Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Rigel Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Rigel Pharmaceuticals stock market strength indicators, traders can identify Rigel Pharmaceuticals entry and exit signals to maximize returns.
Rigel Pharmaceuticals Risk Indicators
The analysis of Rigel Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Rigel Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting rigel stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.43 | |||
| Semi Deviation | 4.06 | |||
| Standard Deviation | 5.79 | |||
| Variance | 33.54 | |||
| Downside Variance | 17.71 | |||
| Semi Variance | 16.45 | |||
| Expected Short fall | (4.34) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Historical Fundamental Analysis of Rigel Pharmaceuticals to cross-verify your projections. For more information on how to buy Rigel Stock please use our How to buy in Rigel Stock guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rigel Pharmaceuticals. If investors know Rigel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rigel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.086 | Earnings Share 6.19 | Revenue Per Share | Quarterly Revenue Growth 0.256 | Return On Assets |
The market value of Rigel Pharmaceuticals is measured differently than its book value, which is the value of Rigel that is recorded on the company's balance sheet. Investors also form their own opinion of Rigel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Rigel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rigel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Rigel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rigel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Rigel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rigel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.